Estrogen nhances malignant phenotypes in human salivary adenoid cystic carcinoma cells

Tomoki Sumida, Akiko Ishikawa, Yu Kamata, hiroyuki nakano, Tomohiro Yamada, Yoshihide Mori

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

抄録

Background/Aim: Adenoid cystic carcinoma (SGC) is a common type of salivary gland cancer (SGC). Surgery is the first treatment choice because chemoradiotherapy is usually not effective. Therefore, new treatment modalities are urgently needed. In this study, it was investigated whether the estrogen axis could be a treatment target or not. Materials and Methods: Adenoid cystic carcinoma (ACC) ACCM cells, were used. The specific cell line lacks estrogen receptor (ER). ER was introduced in ACCM cells, and the effect of 17estradiol (E2) was investigated on cell proliferation, cell-cycle distribution, and cell motility. Results: E2 induced cell proliferation, and the S-phase fraction increased in a dose-dependent manner. Cell motility was also up-regulated compared to control cells. Conclusion: The estrogen/ER system up-regulated malignant phenotypes in ER-positive ACC, and hormone therapy may have a potential as effective treatment for this malignancy.

元の言語英語
ページ(範囲)2793-2798
ページ数6
ジャーナルAnticancer research
36
発行部数6
出版物ステータス出版済み - 6 1 2016

Fingerprint

Adenoid Cystic Carcinoma
Estrogens
Estrogen Receptors
Phenotype
Salivary Gland Neoplasms
Cell Movement
Cell Proliferation
Therapeutics
Chemoradiotherapy
S Phase
Cell Cycle
Hormones
Cell Line
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

Estrogen nhances malignant phenotypes in human salivary adenoid cystic carcinoma cells. / Sumida, Tomoki; Ishikawa, Akiko; Kamata, Yu; nakano, hiroyuki; Yamada, Tomohiro; Mori, Yoshihide.

:: Anticancer research, 巻 36, 番号 6, 01.06.2016, p. 2793-2798.

研究成果: ジャーナルへの寄稿記事

@article{23c54ae03a4742a9a646eed028a403a4,
title = "Estrogen nhances malignant phenotypes in human salivary adenoid cystic carcinoma cells",
abstract = "Background/Aim: Adenoid cystic carcinoma (SGC) is a common type of salivary gland cancer (SGC). Surgery is the first treatment choice because chemoradiotherapy is usually not effective. Therefore, new treatment modalities are urgently needed. In this study, it was investigated whether the estrogen axis could be a treatment target or not. Materials and Methods: Adenoid cystic carcinoma (ACC) ACCM cells, were used. The specific cell line lacks estrogen receptor (ER). ER was introduced in ACCM cells, and the effect of 17estradiol (E2) was investigated on cell proliferation, cell-cycle distribution, and cell motility. Results: E2 induced cell proliferation, and the S-phase fraction increased in a dose-dependent manner. Cell motility was also up-regulated compared to control cells. Conclusion: The estrogen/ER system up-regulated malignant phenotypes in ER-positive ACC, and hormone therapy may have a potential as effective treatment for this malignancy.",
author = "Tomoki Sumida and Akiko Ishikawa and Yu Kamata and hiroyuki nakano and Tomohiro Yamada and Yoshihide Mori",
year = "2016",
month = "6",
day = "1",
language = "English",
volume = "36",
pages = "2793--2798",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Estrogen nhances malignant phenotypes in human salivary adenoid cystic carcinoma cells

AU - Sumida, Tomoki

AU - Ishikawa, Akiko

AU - Kamata, Yu

AU - nakano, hiroyuki

AU - Yamada, Tomohiro

AU - Mori, Yoshihide

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background/Aim: Adenoid cystic carcinoma (SGC) is a common type of salivary gland cancer (SGC). Surgery is the first treatment choice because chemoradiotherapy is usually not effective. Therefore, new treatment modalities are urgently needed. In this study, it was investigated whether the estrogen axis could be a treatment target or not. Materials and Methods: Adenoid cystic carcinoma (ACC) ACCM cells, were used. The specific cell line lacks estrogen receptor (ER). ER was introduced in ACCM cells, and the effect of 17estradiol (E2) was investigated on cell proliferation, cell-cycle distribution, and cell motility. Results: E2 induced cell proliferation, and the S-phase fraction increased in a dose-dependent manner. Cell motility was also up-regulated compared to control cells. Conclusion: The estrogen/ER system up-regulated malignant phenotypes in ER-positive ACC, and hormone therapy may have a potential as effective treatment for this malignancy.

AB - Background/Aim: Adenoid cystic carcinoma (SGC) is a common type of salivary gland cancer (SGC). Surgery is the first treatment choice because chemoradiotherapy is usually not effective. Therefore, new treatment modalities are urgently needed. In this study, it was investigated whether the estrogen axis could be a treatment target or not. Materials and Methods: Adenoid cystic carcinoma (ACC) ACCM cells, were used. The specific cell line lacks estrogen receptor (ER). ER was introduced in ACCM cells, and the effect of 17estradiol (E2) was investigated on cell proliferation, cell-cycle distribution, and cell motility. Results: E2 induced cell proliferation, and the S-phase fraction increased in a dose-dependent manner. Cell motility was also up-regulated compared to control cells. Conclusion: The estrogen/ER system up-regulated malignant phenotypes in ER-positive ACC, and hormone therapy may have a potential as effective treatment for this malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84991583780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991583780&partnerID=8YFLogxK

M3 - Article

C2 - 27272790

AN - SCOPUS:84991583780

VL - 36

SP - 2793

EP - 2798

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -